Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

NCT02573714 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Ketamine
DRUG: Normal Saline
OTHER: Standard Pain Therapy
OTHER: Pediatric Quality of Life - Sickle Cell Disease Module
OTHER: Faces Pain Scale - Revised

Sponsor

Cameroon Baptist Convention Health

Collaborators

[object Object]
[object Object]